Puma Biotechnology (PBYI) Tax Provisions (2020 - 2026)

Puma Biotechnology (PBYI) has 7 years of Tax Provisions data on file, last reported at $326000.0 in Q1 2026.

• Quarterly Tax Provisions rose 11.26% year-over-year to $326000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (up 416.13% YoY) and the FY2025 annual result came in at $1.2 million, up 612.57% from the prior year.
• Tax Provisions rose to $326000.0 in Q1 2026, from $245000.0 in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $399000.0 in Q3 2025 to a low of -$714000.0 in Q4 2024.
• A 5-year average of $156058.8 and a median of $220000.0 in 2024 frame the typical range for Tax Provisions.
• Annual changes were most pronounced in 2023 — Tax Provisions soared 322.36% — and 2024, when it sank 299.44%.
• Tracing PBYI's Tax Provisions over 5 years: stood at -$161000.0 in 2022, then soared by 322.36% to $358000.0 in 2023, then slumped by 299.44% to -$714000.0 in 2024, then jumped by 134.31% to $245000.0 in 2025, then jumped by 33.06% to $326000.0 in 2026.
• The last three Tax Provisions figures came in at $326000.0 (Q1 2026), $245000.0 (Q4 2025), and $399000.0 (Q3 2025), per Business Quant data.